Clinical Oversight and Principal Investigators
Dr. Sanjeev Deva
Medical Director, Principal Investigator
Sanjeev is a New Zealand trained Medical Oncologist who specialises in looking after patients with gastro-intestinal cancer. He completed his Medical Oncology training in Auckland in 2010 and then completed a Clinical Fellowship in Experimental Oncology at Guy’s and St. Thomas’ Hospital in London, UK. Sanjeev returned to Auckland in 2015 as a Medical Oncologist. He has also established the Auckland Cancer Trials Centre at Auckland Hospital and is the current Medical Director. He is the Principal Investigator on many ground-breaking studies and has collaborated with New Zealand’s leading researchers. Sanjeev is a sought-after lecturer, is an invited speaker at national conferences, and is widely published in peer reviewed journals. He prides himself on clear communication and making sure his patients receive the best multidisciplinary care.
Dr. Michelle Wilson
SCD of Cancer and Blood Research, Auckland City Hospital and Principal Investigator
Michelle Wilson is a Staff Medical Oncologist at the Auckland City Hospital, who previously completed a Clinical Research Fellowship in the Drug Development Program at Princess Margaret Cancer Centre. She is the clinical director for Cancer and Blood Research at Auckland Hospital. Her research focus is geared towards early phase translational studies and clinical trials endpoints; in particular, their utility and evolution in an era of precision oncology practice. To this end, she has been involved in the design and development of several novel international trial concepts evaluating PARP inhibitors and immunotherapy. She was recently awarded an MD from the University of Auckland for her work on the challenges facing clinical trial design in oncology. She is an active member of the research advisory committee for the Australia New Zealand Gynaeoncology Group (ANZGOG). She has published in several peer-reviewed journals including Lancet Oncology, Cancer, and Gynecology Oncology and has received a number of grants to enable her research in New Zealand. She prides herself on patient-centred care and increasing research opportunities for patients facing a diagnosis of cancer.
Dr. Peter C. Fong
Dr Peter C. Fong is a Consultant Medical Oncologist at Auckland City Hospital since 2008. He is the Genitourinary Tumour Lead Clinician and an Honorary Academic in the Dept of Pharmacology, Faculty of Medical and Health Sciences, University of Auckland.
Peter is a scholarship holder and first class honours graduate of the University of Queensland, Australia in 1994. He completed his Medical Oncology training at Auckland Hospital in 2003 and then worked as a locum consultant. Peter embarked a fellowship in 2004 at the Drug Development Unit, Royal Marsden Hospital in London, in the conduct of many Phase I studies including olaparib, receiving ASCO Merit Awards. He undertook a research doctorate at the Institute of Cancer Research, the CRUK Centre for Cancer Therapeutics in laboratory translational research in epigenetic targeting drugs and biomarker validation. In 2008, he moved to the Royal Marsden Prostate Cancer Trials Unit. He has been an investigator in over 60 Phase 1 trials.
Peter is a member of the national and Australasian trials groups. He is/was on research and scientific review committees, grants committees and journal review. He has presented in numerous international meetings and published widely in major peer- reviewed medical journals. He has successfully recruited into many trials open in Auckland for the last 10 years.
Professor Ian Judson
Prof Ian Judson read Natural Sciences at Cambridge University, specialising in Biochemistry. He subsequently studied Medicine at King’s College Hospital Medical School and trained in Medical Oncology at the Royal Marsden Hospital. He was awarded an MD from Cambridge in 1988 for work on cancer pharmacology and was appointed Senior Lecturer at The Institute of Cancer Research (ICR) in 1989 and has been Professor of Cancer Pharmacology at the ICR since 2001. His work initially focused on the development of new anticancer drugs, including raltitrexed, temozolomide, abiraterone acetate and everolimusbut expanded into the field of sarcoma in which he now has 25 years’ experience. He was involve in the initial clinical trials of imatinib in gastrointestinal stromal tumour, subsequently being involved in the development of a number of other drugs for this disease.
Prof Ian Judson has been chief investigator for many national and international sarcoma trials and has held the positions of President, Connective Tissue Oncology Society, President, British Sarcoma Group and Chairman, EORTC Soft Tissue and Bone Sarcoma Group (STBSG), of which he is currently Treasurer. He was for many years Head of The Royal Marsden’s Sarcoma Unit and the Sarcoma Clinical Trials team at the ICR.
Dr Angela Mweempwa
Dr Edmond Ang
Dr Alistair Wickham
Clinical Research Nurses
Clinical Research Coordinators
Auckland Cancer Trials Centre
Auckland City Hospital,
2, Park Road, Grafton,
1023, Auckland, New Zealand
Please email all referrals to: CentralReferrals@adhb.govt.nz (include Att: ACTC in email subject)